Video

Axel Hoos on the ATOM Initiative

Axel Hoos, M.D., Ph.D. of GlaxoSmithKline discusses the ATOM Initiative.

Axel Hoos, M.D., Ph.D., Head of Oncology of GlaxoSmithKline (GSK), discusses the ATOM Initiative.

Joining with the Department of Energy and the National Cancer Insitute, GSK is working on in silico screening. The ATOM Initiative uses a super-computer, owned by the Department of Energy to rapidly identify potential new pharmacuetical agents to target cancer. This super-computer can screen the compounds much faster than any other computer that exists. This initiative is still in the pilot stage as it is a completely novel concept.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
image of gerds
Image of 2 doctors and text.
Image of two doctors and text.
Image of man.
Image of thumbnail.
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency
Image of woman.
Image of two people.
Related Content